Skip to main content

Table 1 Summary of patient characteristics

From: Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

Characteristic Number Percent
Age (years) median: 56 range: 27–78
  < 60 49 65.3
  > 60 26 34.7
Sex
 Male 40 53
 Female 35 47
Localization of primary
 Pancreas 50 66.6
 Midgut 11 14.6
 Bronchus 6 8
 Stomach 1 1.3
 Hindgut 2 2.6
 Thymus 1 1.3
 Unknown 4 5.3
Tumor grading
 G1 27 36
 G2 34 45
 Unspecified 14 19
Prior treatment
 1 prior treatment 24 32
  > 1 prior treatment 43 57
 No pretreatment 4 5.3
 No data available 4 5.3
Metastases
 No metastases (locally advanced) 2 2.6
 Liver only 33 44
 Liver plus additional
 Extrahepatic metastases
 (Bone, lung, spleen)
40 53